News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ryan Jason
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Ryan Jason (Director) has filed a Form 4 on SomaLogic, Inc.|
Txns:
| Granted 185,400 options to buy
@ $2.74, valued at
$508k
Granted 14,650 options to buy
@ $2.74, valued at
$40.1k
Granted 3,400 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| Ryan Jason (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 74,000 options to buy
@ $1.06, valued at
$78.4k
|
|
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Ryan Jason (Executive Chairman) has filed a Form 4 on Sema4 Holdings Corp.|
Txns:
| Sold 73,732 shares
@ $0.2619, valued at
$19.3k
Exercised 247,525 restricted stock units
@ $0 |
|
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Ryan Jason (Director) has filed a Form 4 on Sema4 Holdings Corp.|
Txns:
| Granted 429,730 options to buy
@ $3.45, valued at
$1.5M
Granted 247,525 restricted stock units
@ $0 |
|
| 10/19/2021 |
4
| Ryan Jason (Director) has filed a Form 4 on Sema4 Holdings Corp.|
Txns:
| Granted 22,286 options to buy
@ $7.79, valued at
$173.6k
Granted 12,836 restricted stock units
@ $0 |
|
| 07/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Ryan Jason (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 329,379 options to buy
@ $6, valued at
$2M
|
|
| 01/04/2019 |
3
| Ryan Jason (See Remarks) has filed a Form 3 on Magenta Therapeutics, Inc. |
| 08/02/2018 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Unknown transaction of 6,955 shares
@ $137, valued at
$952.8k
Disposed of 42,215 shares
@ $137, valued at
$5.8M
Unknown transaction of 1,562 options to buy
@ $7.12, valued at
$11.1k
|
|
| 07/05/2018 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 3,403 shares
@ $136.66, valued at
$465.1k
|
|
| 04/18/2018 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 3,449 shares
@ $74.3, valued at
$256.3k
|
|
| 04/05/2018 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 1 shares
@ $72.4, valued at
$72.4 |
|
| 04/03/2018 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Granted 12,932 shares
@ $78.75, valued at
$1M
Sold 3,109 shares
@ $77.55, valued at
$241.1k
Sold 3,030 shares
@ $74.87, valued at
$226.9k
|
|
| 03/19/2018 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 7,147 shares
@ $78.26, valued at
$559.3k
Sold 7,853 shares
@ $78.26, valued at
$614.6k
Exercised 7,147 options to buy
@ $29.63, valued at
$211.8k
Exercised 7,853 options to buy
@ $29.63, valued at
$232.7k
|
|
| 02/20/2018 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 15,000 shares
@ $67.53, valued at
$1M
Exercised 15,000 options to buy
@ $29.63, valued at
$444.5k
|
|
| 01/18/2018 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 1,035 shares
@ $64.38, valued at
$66.6k
Sold 20,000 shares
@ $64.38, valued at
$1.3M
Exercised 20,000 options to buy
@ $29.63, valued at
$592.6k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2017 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 3,038 shares
@ $61.26, valued at
$186.1k
Sold 18,688 shares
@ $61.26, valued at
$1.1M
Exercised 3,038 options to buy
@ $0.08, valued at
$243
Exercised 18,688 options to buy
@ $7.12, valued at
$133.1k
|
|
| 11/06/2017 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 9,731 shares
@ $50, valued at
$486.6k
|
|
| 10/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2017 |
4
| Ryan Jason (CFO) has filed a Form 4 on Foundation Medicine, Inc.|
Txns:
| Sold 1,233 shares
@ $31.96, valued at
$39.4k
|
|
|
|
|